Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002

The present study reports on all deaths related to taking ecstasy (alone, or in a polydrug combination) occurring in England and Wales in the time frame August 1996–April 2002. Data presented here are based on all information recorded in the National Programme on Substance Abuse Deaths (np‐SAD) database. The np‐SAD regularly receives all information on drug related deaths in addicts and non addicts from coroners. A total of 202 ecstasy‐related fatalities occurred in the chosen time‐frame, showing a steady increase in the number of deaths each year. The ratio male:female was 4:1 and 3 of 4 victims were younger than 29. In 17% of cases ecstasy was the sole drug implicated in death and in the remaining cases a number of other drugs (mostly alcohol, cocaine, amphetamines and opiates) have been found. According to toxicology results, MDMA accounted for 86% of cases and MDA for 13% of cases; single deaths were associated with MDEA and PMA. This is the largest sample of ecstasy related deaths so far; possible explanations are given for the observed steady increase in ecstasy‐related deaths and a tentative ‘rationale’ for this polypharmacy combination is then proposed. Copyright © 2003 John Wiley & Sons, Ltd.

[1]  E. Vuori,et al.  Death following ingestion of MDMA (ecstasy) and moclobemide. , 2003, Addiction.

[2]  L. Webb,et al.  Review of deaths related to taking ecstasy, England and Wales, 1997-2000 , 2003, BMJ : British Medical Journal.

[3]  R. Pihl,et al.  Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[4]  J. Ramsey,et al.  4-MTA: a new synthetic drug on the dance scene. , 2002, Drug and alcohol dependence.

[5]  A. Daly,et al.  CYP2D6 deficiency, a factor in ecstasy related deaths? , 2002, British journal of clinical pharmacology.

[6]  M. Farré,et al.  Cell‐Mediated Immune Response in MDMA Users After Repeated Dose Administration , 2002 .

[7]  M. Brecht,et al.  Differences Between Ecstasy-Using and Nonusing Methamphetamine Users , 2002, Journal of psychoactive drugs.

[8]  A. Parrott,et al.  Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity , 2002, Pharmacology Biochemistry and Behavior.

[9]  A. Parrott.  Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.

[10]  J. Ramsey,et al.  A new method to monitor drugs at dance venues , 2001, BMJ : British Medical Journal.

[11]  A. Parrott,et al.  Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug , 2001, Journal of psychopharmacology.

[12]  P. Tossmann,et al.  The Use of Drugs within the Techno Party Scene in European Metropolitan Cities , 2001, European Addiction Research.

[13]  I. Spruit,et al.  MONITORING SYNTHETIC DRUG MARKETS, TRENDS, AND PUBLIC HEALTH , 2001, Substance use & misuse.

[14]  Fiona Measham,et al.  Dancing on Drugs: Risk, Health and Hedonism in the British Club scene , 2000 .

[15]  H. Christensen,et al.  [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning]. , 1999, Ugeskrift for laeger.

[16]  S. Gore.  Fatal uncertainty: death-rate from use of ecstasy or heroin , 1999, The Lancet.

[17]  F. Schifano,et al.  MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. , 1998, Drug and alcohol dependence.

[18]  H. Curran,et al.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.

[19]  J. Veuthey,et al.  [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity]. , 1997, Praxis.

[20]  Michael J A Parr,et al.  Hyponatraemia and death after “ecstasy” ingestion , 1997, The Medical journal of Australia.

[21]  J. Henry.  Ecstasy and the dance of death. , 1992, BMJ.

[22]  R. de la Torre,et al.  Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. , 2002, Annals of the New York Academy of Sciences.

[23]  C. Sharp,et al.  Prevalence of drug use: key findings from the 2001/2002 British Crime Survey. , 2002 .

[24]  Malcolm Ramsay,et al.  Drug misuse declared in 2000: results from the British Crime Survey , 2001 .